Epithelial cancers compounds (Kalgene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEpithelial cancers compounds (Kalgene)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKalgene Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKalgene Pharma Inc
Active IndicationsN/A
Inactive IndicationsThyroid Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A